These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 710477)

  • 21. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
    Simmons RL; Rios A
    Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunotherapy in the treatment of acute leukaemia.
    Whittaker JA
    Br J Haematol; 1980 Jun; 45(2):187-93. PubMed ID: 6934004
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunotherapy of autochthomous rat methylcholanthrene-induced sarcomas with a mixture of allogeneic tumor cells and BCG-CWS.
    Kudo H; Suga M; Waga T; Ogasawara M; Sato T; Usubuchi I
    Tohoku J Exp Med; 1980 Jan; 130(1):49-53. PubMed ID: 7368205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy in an intracerebral murine glioma model, using Bacillus Calmette-Guérin, neuraminidase-treated tumor cells, and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Albright L; Madigan JC; Gaston MR; Houchens DP
    Cancer Res; 1975 Mar; 35(3):658-65. PubMed ID: 234790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experiments on the treatment of Yoshida tumor with neuroaminidase of Vibrio cholerae].
    Sánchez Cousteau JA; Justo Alpañes E; Ledro Molina D; Ferreiro Madueño M; Gomez Parra M; Ramírez Martínez R; Valle Bernal MJ; Astolfi Pérez de Guzmán J; Garrido Peralta M
    Rev Clin Esp; 1979 Sep; 154(5):183-6. PubMed ID: 523718
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of experimental metastatic spread by nonspecific stimulants.
    Arnold W; Muresian TM; Kiricuta I; Graffi A
    Oncology; 1977; 34(4):156-8. PubMed ID: 917448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCG immunotherapy of rat tumours in athymic nude mice.
    Pimm MV; Baldwin RW
    Nature; 1975 Mar; 254(5495):77-8. PubMed ID: 234599
    [No Abstract]   [Full Text] [Related]  

  • 29. Suppression of transplanted rat sarcomata mediated by Bacillus Calmette Guéin (BCG).
    Moore M; Lawrence N; Witherow PJ
    Eur J Cancer (1965); 1974 Oct; 10(10):673-82. PubMed ID: 4533899
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the effectiveness of regional interleukin-2 dependent adoptive immunocytotherapy of mice with transplanted rhabdomyosarcoma].
    Semenova-Kobzar' RA; Iudin VM; Kushko LIa; Iakhimovich LV; Berezhnaia NM
    Eksp Onkol; 1990; 12(3):50-2. PubMed ID: 2344825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proceedings: Host immune responses in B.C.G. therapy of a rat osteosarcoma.
    Lawrence N; Moore M
    Br J Cancer; 1974 Jan; 29(1):95. PubMed ID: 4522736
    [No Abstract]   [Full Text] [Related]  

  • 32. Controlled clinical trial of adjuvant immunotherapy with BCG and neuraminidase-treated autologous tumour cells in large bowel cancer.
    Gray BN; Walker C; Andrewartha L; Freeman S; Bennett RC
    J Surg Oncol; 1989 Jan; 40(1):34-7. PubMed ID: 2642566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectivity of living and non-living BCG vaccine on experimental metastatic spread in mice and the stimulation of the reticulohistiocytic system (RHS).
    Arnold W; Fey F; Graffi A
    Neoplasma; 1981; 28(5):549-54. PubMed ID: 7312074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of Bacillus Calmette-Guérin (BCG) infection to suppress the growth of transplanted mouse and rat sarcomas.
    Símová J; Bubeník J
    Folia Biol (Praha); 1973; 19(4):296-300. PubMed ID: 4356560
    [No Abstract]   [Full Text] [Related]  

  • 35. Methanol extraction residue of BCG in the treatment of transplanted rat tumours.
    Hopper DG; Pimm MV; Baldwin RW
    Br J Cancer; 1975 Feb; 31(2):176-81. PubMed ID: 169861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Adjuvant contact suppression of experimental tumours.
    Pimm MV; Hoppes DG
    Lancet; 1975 Apr; 1(7910):806. PubMed ID: 48032
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunotherapy with irradiated tumour cells and BCG in experimental osteosarcoma.
    Larsson SE; Lorentzon R; Boquist L
    Acta Orthop Scand; 1981 Oct; 52(5):469-74. PubMed ID: 6949451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphatic metastasis and its inhibition: an experimental model.
    Carr I; McGinty F
    J Pathol; 1974 Jun; 113(2):85-95. PubMed ID: 4420735
    [No Abstract]   [Full Text] [Related]  

  • 39. BCG therapy of pleural and peritoneal growth of transplanted rat tumours.
    Pimm MV; Baldwin RW
    Int J Cancer; 1975 Feb; 15(2):260-9. PubMed ID: 165155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization of Rous sarcoma virus-inoculated marmosets with BCG and transformed allogeneic cells.
    Schauf V; Massey R; Deinhardt F; Kruse R
    J Natl Cancer Inst; 1975 Jan; 54(1):151-5. PubMed ID: 163312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.